Is Less More: Does Leukopenia Predict Remission in Patients with Inflammatory Bowel Disease Receiving Thiopurine Treatment?

被引：2
|
作者：
Gisbert, Javier P. [1 ,2 ]
机构：
[1] Hosp Univ La Princesa, Gastroenterol Unit, Inst Invest Sanitaria Princesa, Madrid 28669, Spain
[2] Hosp Univ La Princesa, Ctr Invest Biomed Red Enfermedades Hepaticas & Di, Madrid 28669, Spain
来源：
DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 01期
关键词：
AZATHIOPRINE THERAPY; 6-MERCAPTOPURINE; NEUTROPENIA;
D O I：
10.1007/s10620-014-3481-z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：4 / 6
页数：3
相关论文
共 50 条
  • [31] Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease
    Xian-Wen Dong
    World Journal of Gastroenterology, 2010, 16 (25) : 3187 - 3195
  • [32] Thiopurine adverse events in patients with inflammatory bowel disease in the UK: inflammatory bowel disease BioResource cohort
    Hong, Y. Y.
    Withanachchi, D. A.
    Aslam, S. P.
    Khalid, Y.
    Shawky, R.
    Parkes, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S395 - S396
  • [33] DEOXYTHIOGUANOSINE (DTG) IN DNA AS A PHARMACOLOGICAL ENDPOINT OF THIOPURINE TREATMENT IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Coulthard, S.
    Berry, P.
    McGarrity, S.
    Kobayashi, T.
    Toyonaga, T.
    Ansari, A.
    Redfern, C.
    GUT, 2016, 65 : A261 - A261
  • [34] Care of inflammatory bowel disease patients in remission
    Subramanian, Charumathi Raghu
    Triadafilopoulos, George
    GASTROENTEROLOGY REPORT, 2016, 4 (04): : 261 - 271
  • [35] A QSP approach to predict clinical outcomes of thiopurine therapy in inflammatory bowel disease
    Siripuram, Vijay K.
    Wright, Daniel F. B.
    Barclay, Murray L.
    Duffull, Stephen B.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S118 - S118
  • [36] Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs
    Sheffield, Leslie J.
    Irving, Peter
    Gupta, Arun
    Byron, Keith
    Macrae, Finlay A.
    Phillimore, Hazel
    Dronavalli, Mithilesh
    Rose, Rosemary
    George, Peter
    Walmsley, Trevor
    Dixon, Barbara
    Poole, Susan
    Dooley, Michael
    Sparrow, Miles
    PHARMACOGENOMICS, 2009, 10 (07) : 1091 - 1099
  • [37] Letter: thiopurine blood monitoring for patients with inflammatory bowel disease
    El-Matary, W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (06) : 742 - 742
  • [38] Therapeutic options for patients with inflammatory bowel disease: Thiopurine immunosuppressants
    Brynskov, J
    DRUGS OF TODAY, 1997, 33 (06): : 413 - 419
  • [39] Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease
    Lopez-Martin, Cristina
    Chaparro, Maria
    Espinosa, Laura
    Bejerano, Alicia
    Mate, Jose
    Gisbert, Javier P.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (06): : 385 - 392
  • [40] Risk of Nephrolithiasis in Patients with Inflammatory Bowel Disease Receiving Biologic Treatment
    Alameddine, Zakaria
    Melhem, Racha Abi
    Dimachkie, Reem
    Rabah, Hussein
    Chehab, Hamed
    El Khoury, Michel
    Qaqish, Faris
    Stefanov, Dimitre
    El-Sayegh, Suzanne
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
12345